0 251

Cited 0 times in

p16 is a major inactivation target in hepatocellular carcinoma

DC Field Value Language
dc.contributor.author김호근-
dc.contributor.author박전한-
dc.contributor.author박찬일-
dc.contributor.author박전한-
dc.contributor.author박찬일-
dc.date.accessioned2019-11-11T05:03:53Z-
dc.date.available2019-11-11T05:03:53Z-
dc.date.issued2000-
dc.identifier.issn0008-543X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/171584-
dc.description.abstractBACKGROUND: The p16(INK4A) gene encodes 2 cell cycle regulator proteins, p16 and p14(ARF), by alternative splicing. This genetic locus also contains another cell cycle regulator gene, p15(INK4B), which encodes p15. The inactivation of the p16 protein has been demonstrated in some hepatocellular carcinomas (HCCs); however, the inactivation of the other 2 cell regulator proteins and their inactivation patterns are not well characterized. METHODS: To characterize the role of the above 3 cell cycle regulator proteins in HCCs, the authors examined the genomic status of the p16(INK4A) and p15(INK4B) genes and their RNA products in 20 HCC tissues and 7 human HCC cell lines. Homozygous deletions in each exon of p16(INK4A) and p15(INK4B) were evaluated by comparative multiplex polymerase chain reaction (PCR), and the methylation status of the p16(INK4A) and p15(INK4B) promoter region was analyzed by methylation specific PCR. RESULTS: Homozygous deletions were found in 6 of 20 HCCs (30%) and 2 of 7 HCC cell lines (29%). In 20 HCCs, the frequency of homozygous deletions was 20% in exon 1 of p15(INK4B), 20% in exon 2 of p15(INK4B), 10% in exon 1beta of p16(INK4A), 25% in exon 1alpha of p16(INK4A), 15% in exon 2 of p16(INK4A), and 15% in exon 3 of p16(INK4A). The authors found hypermethylation of the p16(INK4A) promoter region in 7 HCCs (35%) and 3 HCC cell lines (43%). The overall frequency of p16 alterations in HCCs, including hypermethylation and homozygous deletions, was 60% (12 of 20 cases). According to reverse transcriptase-PCR analysis, the absence of RNA expression was most frequent in p16 (11 of 20 cases, 55%) and less frequent in p15 (7 of 20 cases, 35%) and p14(ARF) (5 of 20 cases, 25%). CONCLUSIONS: Among the 3 cell cycle regulator proteins encoded at the 9p21 genetic locus, inactivation of p16 is the most frequent event in HCCs in which promoter hypermethylation and homozygous deletions are the common mechanisms.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherWiley-
dc.relation.isPartOfCancer-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCarcinoma, Hepatocellular/genetics*-
dc.subject.MESHCell Cycle Proteins*-
dc.subject.MESHCell Transformation, Neoplastic-
dc.subject.MESHCyclin-Dependent Kinase Inhibitor p15-
dc.subject.MESHCyclin-Dependent Kinase Inhibitor p16/genetics-
dc.subject.MESHDNA, Neoplasm/genetics-
dc.subject.MESHGene Deletion-
dc.subject.MESHGenes, p16/genetics*-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms/genetics*-
dc.subject.MESHMethylation-
dc.subject.MESHPromoter Regions, Genetic/genetics*-
dc.subject.MESHProteins/genetics-
dc.subject.MESHRNA/genetics-
dc.subject.MESHTranscription Factors/genetics-
dc.subject.MESHTumor Suppressor Protein p14ARF-
dc.subject.MESHTumor Suppressor Proteins*-
dc.titlep16 is a major inactivation target in hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학교실)-
dc.contributor.googleauthorMyung Jin Baek-
dc.contributor.googleauthorZhe Piao-
dc.contributor.googleauthorNam-Gyun Kim-
dc.contributor.googleauthorChanil Park-
dc.contributor.googleauthorEui-Cheol Shin-
dc.contributor.googleauthorJeon-Han Park-
dc.contributor.googleauthorHee-Jung Jung-
dc.contributor.googleauthorChul Geun Kim-
dc.contributor.googleauthorHoguen Kim-
dc.identifier.doi10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO;2-3-
dc.contributor.localIdA01183-
dc.contributor.localIdA01641-
dc.contributor.localIdA01641-
dc.contributor.localIdA01710-
dc.contributor.localIdA01710-
dc.contributor.localIdA01641-
dc.contributor.localIdA01641-
dc.contributor.localIdA01710-
dc.contributor.localIdA01710-
dc.relation.journalcodeJ00434-
dc.identifier.eissn1097-0142-
dc.identifier.pmid10897001-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142%2820000701%2989%3A1%3C60%3A%3AAID-CNCR9%3E3.0.CO%3B2-3-
dc.subject.keywordp16INK4A-
dc.subject.keywordp15INK4B-
dc.subject.keywordp14ARF-
dc.subject.keywordhomozygous deletions-
dc.subject.keywordmethylation inacti-vation-
dc.contributor.alternativeNameKim, Ho Keun-
dc.contributor.affiliatedAuthor김호근-
dc.contributor.affiliatedAuthor박전한-
dc.contributor.affiliatedAuthor박전한-
dc.contributor.affiliatedAuthor박찬일-
dc.contributor.affiliatedAuthor박찬일-
dc.contributor.affiliatedAuthor박전한-
dc.contributor.affiliatedAuthor박전한-
dc.contributor.affiliatedAuthor박찬일-
dc.contributor.affiliatedAuthor박찬일-
dc.citation.volume89-
dc.citation.number1-
dc.citation.startPage60-
dc.citation.endPage68-
dc.identifier.bibliographicCitationCancer, Vol.89(1) : 60-68, 2000-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.